Active funding or within 5 years
Total >£18M; Principal [or chief investigator] PI: >£3.8M; Co-Investigator [CI]: >£14M
Selected grants:
1. MRC-DPFS: Development of a novel host blood test using TRanscripts to Identify bacterial Meningitis (TRIM study). PI Costed extension to October 2025 approved.
2. Newton Fund/MRC: Diagnostic Improvement of Meningo-Encephalitis in Indonesia (DIME study) - using novel and established molecular diagnostic tools. PI £34,132 2022-ongoing (supplement)
3. Health Education and Innovation Funding (HEIF): Developing novel diagnostic tools in partnership with BlinxDX PI £30,034 2022-ongoing
4. Health Education and Innovation Funding (HEIF): Developing novel diagnostic tools in partnership with Dam Health and Medtechtomarket PI £51,240 02/2022
5. MRC-DPFS: Development of a novel host blood test using TRanscripts to Identify bacterial Meningitis (TRIM study). PI £1.69M (MRC+Industry funding) 03/2019-03/2022
6. Newton Fund: Diagnostic Improvement of Meningo-Encephalitis in Indonesia (DIME study) - using novel and established molecular diagnostic tools. PI £419,510 04/2019
7. MRC CiC: CSF peptide data set to accurately diagnose bacterial infection in neuro-surgical patients” PI £59,999 10/2019
8. Fast Track Diagnostics (Industry): Improving diagnosis of CNS infections through pathogen specific NAAT. Co-PI £411,877 05/2014
9. MRC CiC: Employing Next Generation Sequencing to enhance diagnosis of neurosurgical cerebrospinal fluid shunt infection. £24,999 09/21 Collaboration with University of California San Francisco (UCSF)
10. UKRI: The COVID-19 Clinical Neuroscience Study (COVID-CNS) Paediaitric lead; £1,986,056 10/2020
11. National Institute of Health Research (NIHR): DexEnceph: Dexamethasone in Herpes Simplex Virus Encephalitis Randomised Controlled Trial. Co-I £145,126, Supplement: 06/2021
12. NIHR: DexEnceph: Dexamethasone in Herpes Simplex Virus Encephalitis Randomised Controlled Trial. Co-I £1,331,779 01/2021
13. NIHR: Global Health Research Group (GHRG) on Improving the Management of Acute Brain Infections at University of Liverpool Co-I £237,075 Suppl. 03/2021
14. NIHR: COVID-Neuro: COVID-19 Neurological Disease: a Global Meta-Analysis and Prospective Case Control Study in Brazil, India and Malawi. Co-I £932,541 10/2020
15. NIHR Health Protection Research Unit: Emerging & Zoonotic Infections Co-I £3,891,432 04/2020
16. Enceph-Ig NIHR Efficacy Mechanism Evaluation Program Co-I £3,225,92 04/2020
17. NIHR: Global Health Research Group (GHRG study) on Improving the Management of Acute Brain Infections at University of Liverpool Co-I £1,348,992 03/2018
18. Wellcome Trust: Empowering communities affected by Zika Virus – Zika Engagement, Support and Training PI £63,750 03/2017
19. EU: Zika Preparedness Latin American Network (ZikaPLAN): Co-I £900,790 10/2016
20. MRC: Improving diagnostics for Zika infection (IDZI study) through Fiocruz, Brazil, Laboratorio de Virología, Colombia and Liverpool-Public Health England. PI £101,025 03/2016
21. Wellcome Trust: Childhood Aetiology of Severe Encephalopathy in Malawi (CHASE study); Clinical PhD Fellowship: Primary Supervisor (Dr S Ray) £354,13 10/2017
22. Wellcome Trust: Risk factors for and spatio-temporal distribution of cases of acute encephalitis syndrome in northern Viet Nam. Clinical PhD Fellowship: Primary Supervisor (Dr H Brindle) £382,839 10/2014